Tuesday, April 29, 2025
wellness India Expo
Home Tags NLRP3

Tag: NLRP3

Zydus Lifesciences receives approval from USFDA to conduct Phase II(b) clinical...

Usnoflast is a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS)